Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...

A 64-year-old long-distance runner, Todd Elworthy was alarmed and confused when his routine prostate specific antigen (PSA) test was elevated in 2023, and a biopsy came back positive for prostate ...

A large trial of people with earlier stages of prostate cancer compared two types of external radiation treatments head-to-head—proton beam therapy and intensity-modulated radiation therapy, or ...

Patient-reported quality of life (QoL) was similar between proton beam therapy (PBT) and intensity-modulated radiation therapy (IMRT) among men with localized prostate cancer, the randomized PARTIQoL ...

SOMERSET, N.J., March 24, 2026 /PRNewswire/ -- Millions of men are already blocking time on their calendars for college basketball's biggest month. ProCure Proton Therapy Center, located right here in ...

SOMERSET, N.J., Feb. 13, 2026 /PRNewswire/ -- In recognition of National Cancer Prevention Month, ProCure Proton Therapy Center is urging men to prioritize prostate-specific antigen (PSA) ...

WASHINGTON, September 30, 2024 — People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy — proton beam therapy or intensity modulated ...

People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy - proton beam therapy or intensity modulated radiation therapy (IMRT) - ...

ProCure Proton Therapy Center has launched a new awareness initiative aimed at helping patients and families better understand proton therapy—an advanced radiation treatment designed to protect ...

Proton beam therapy does not improve the patient-reported outcome of bowel function compared with IMRT. Bowel side effects do not differ between patients with localized prostate cancer who receive ...